Design and evaluation of pilicides: potential novel antibacterial agents directed against uropathogenic Escherichia coli. 2001

A Svensson, and A Larsson, and H Emtenäs, and M Hedenström, and T Fex, and S J Hultgren, and J S Pinkner, and F Almqvist, and J Kihlberg
Organic Chemistry 2, Center for Chemistry and Chemical Engineering, Lund Institute of Technology, Lund University P.O. Box 124, SE-221 00 Lund, Sweden.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D010861 Fimbriae, Bacterial Thin, hairlike appendages, 1 to 20 microns in length and often occurring in large numbers, present on the cells of gram-negative bacteria, particularly Enterobacteriaceae and Neisseria. Unlike flagella, they do not possess motility, but being protein (pilin) in nature, they possess antigenic and hemagglutinating properties. They are of medical importance because some fimbriae mediate the attachment of bacteria to cells via adhesins (ADHESINS, BACTERIAL). Bacterial fimbriae refer to common pili, to be distinguished from the preferred use of "pili", which is confined to sex pili (PILI, SEX). Bacterial Fimbriae,Bacterial Pili,Common Fimbriae,Common Pili,Pili, Bacterial,Pili, Common,Bacterial Fimbria,Bacterial Pilus,Common Fimbria,Common Pilus,Fimbria, Bacterial,Pilus, Bacterial,Fimbria, Common,Fimbriae, Common,Pilus, Common
D011728 Pyridones Pyridine derivatives with one or more keto groups on the ring. Pyridinones
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001425 Bacterial Outer Membrane Proteins Proteins isolated from the outer membrane of Gram-negative bacteria. OMP Proteins,Outer Membrane Proteins, Bacterial,Outer Membrane Lipoproteins, Bacterial
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs

Related Publications

A Svensson, and A Larsson, and H Emtenäs, and M Hedenström, and T Fex, and S J Hultgren, and J S Pinkner, and F Almqvist, and J Kihlberg
January 2022, Journal of pharmacy & bioallied sciences,
A Svensson, and A Larsson, and H Emtenäs, and M Hedenström, and T Fex, and S J Hultgren, and J S Pinkner, and F Almqvist, and J Kihlberg
June 2014, Journal of medicinal chemistry,
A Svensson, and A Larsson, and H Emtenäs, and M Hedenström, and T Fex, and S J Hultgren, and J S Pinkner, and F Almqvist, and J Kihlberg
December 2020, Journal of enzyme inhibition and medicinal chemistry,
A Svensson, and A Larsson, and H Emtenäs, and M Hedenström, and T Fex, and S J Hultgren, and J S Pinkner, and F Almqvist, and J Kihlberg
March 2016, Journal of the American Society of Nephrology : JASN,
A Svensson, and A Larsson, and H Emtenäs, and M Hedenström, and T Fex, and S J Hultgren, and J S Pinkner, and F Almqvist, and J Kihlberg
August 1998, Research communications in molecular pathology and pharmacology,
A Svensson, and A Larsson, and H Emtenäs, and M Hedenström, and T Fex, and S J Hultgren, and J S Pinkner, and F Almqvist, and J Kihlberg
June 2013, BMC microbiology,
A Svensson, and A Larsson, and H Emtenäs, and M Hedenström, and T Fex, and S J Hultgren, and J S Pinkner, and F Almqvist, and J Kihlberg
September 2021, Nanoscale research letters,
A Svensson, and A Larsson, and H Emtenäs, and M Hedenström, and T Fex, and S J Hultgren, and J S Pinkner, and F Almqvist, and J Kihlberg
January 1998, Advances in experimental medicine and biology,
A Svensson, and A Larsson, and H Emtenäs, and M Hedenström, and T Fex, and S J Hultgren, and J S Pinkner, and F Almqvist, and J Kihlberg
February 2012, European journal of medicinal chemistry,
A Svensson, and A Larsson, and H Emtenäs, and M Hedenström, and T Fex, and S J Hultgren, and J S Pinkner, and F Almqvist, and J Kihlberg
October 2023, BMC microbiology,
Copied contents to your clipboard!